Abcam’s TNF alpha Rat in vitro ELISA (Enzyme-Linked Immunosorbent Assay) kit is designed for the quantitative measurement of Rat TNF alpha in cell culture supernatants, serum and plasma samples. A monoclonal antibody specific for TNF alpha has been coated onto the wells of the microtiter strips provided. Samples, including standards of known TNF alpha concentrations, control specimens or unknowns are pipetted into these wel…
Multiplex miRNA assays with FirePlex particle technology enables simultaneous profiling of 65 miRNAs directly from small amounts of biofluid or FFPE, without RNA purification or pre-amplification, with assay readout on a standard flow cytometer
LDH Assay Kit (Cytotoxicity) ab65393 uses WST for the fast and sensitive detection of LDH released from damaged cells.
Very high binding capacity (>30 mg IgG/mL) cell culture medium. Minimal leaching of ligand. Suitable for column or batch purification of IgG, immunoprecipitation & ChIP.
Trichrome Stain Kit (Connective Tissue Stain) ab150686 is intended for use in the histological visualization of collagenous connective tissue fibers in tissue sections.
Rhodamine Phalloidin Reagent ab235138 is one of a series of phalloidin conjugates that are used to stain actin filaments in fluoresence microscopy. The tetramethyl rhodamine dye can be easily detected with a fluorescent microscope at Ex/Em = 546/575 nm.
Human Complement C3 ELISA kit is a competitive immunoassay designed for the quantitative measurement of Complement C3 in human plasma and serum.
Primarily directed against mature 17kDa human IL-1beta. In ELISA formats and other immunoreactive assays, the antibody will recognize 10% of the non-denatured (native) 31kDa IL-1beta precursor containing samples, but will detect all of the 17kDa mature molecule. Also detects primate IL-1beta in the same formats using similar dilutions.
Key features and details Assay type: Quantitative Detection method: Colorimetric Platform: Microplate reader Assay time: 30 min Sample type: Cell culture supernatant, Cell Lysate, Other biological fluids, Plasma, Serum, Tissue Lysate, Urine Sensitivity: 0.02 mM
Knockout achieved by using CRISPR/Cas9, Homozygous: 4 bp deletion in exon 3
Knockout achieved by using CRISPR/Cas9, Homozygous: 1 bp insertion in exon 4
Knockout achieved by using CRISPR/Cas9, 1 bp deletion in exon 2 and Insertion of the selection cassette in exon 2
Knockout achieved by using CRISPR/Cas9, 1 bp deletion in exon 4 and Insertion of the selection cassette in exon 4
Knockout achieved by using CRISPR/Cas9, Homozygous: 1 bp insertion in exon 5
Knockout achieved by using CRISPR/Cas9, Homozygous: Insertion of the selection cassette in exon 1
Knockout achieved by using CRISPR/Cas9, Homozygous: Insertion of the selection cassette in exon 2
Knockout achieved by using CRISPR/Cas9, 2 bp deletion in exon 6 and Insertion of the selection cassette in exon 6
Knockout achieved by using CRISPR/Cas9, 1 bp deletion in exon 12 and 4 bp deletion in exon 12
Knockout achieved by using CRISPR/Cas9, Homozygous: Insertion of the selection cassette in exon 1
Knockout achieved by using CRISPR/Cas9, 16 bp deletion in exon 2 and 1 bp insertion in exon 2
Knockout achieved by using CRISPR/Cas9, Homozygous: 1 bp deletion in exon 4
Knockout achieved by using CRISPR/Cas9, Homozygous: 1 bp insertion in exon 10
Knockout achieved by using CRISPR/Cas9, Homozygous: 5 bp deletion in exon 3
Knockout achieved by using CRISPR/Cas9, Homozygous: 1 bp insertion in exon 2
Knockout achieved by using CRISPR/Cas9, 2 bp deletion in exon 1 and 2 bp insertion in exon 1
